Search for: "Federal, Inc."
Results 1101 - 1120
of 57,559
Sorted by Relevance
|
Sort by Date
24 Jun 2011, 7:00 am
Therasense, Inc. v. [read post]
7 May 2020, 4:15 am
On May 5, the United States Court of Appeals for the Federal Circuit (CAFC) reversed a decision of the United States Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) in Uber Technologies, Inc., v. [read post]
22 Feb 2024, 4:29 pm
Insider Inc. v. [read post]
15 Nov 2018, 1:20 pm
Court of Appeals for the Federal Circuit, Oct. 30, 2018, Converse, Inc. v. [read post]
22 Mar 2017, 2:00 am
SW General, Inc., dba Southwest Ambulance. [read post]
23 Jan 2018, 3:03 pm
The ABA’s amicus brief supports the petition by Nantkwest Inc., which owns the cancer treatment patent application in question, and asks the full Federal Circuit to reverse that decision. [read post]
14 Nov 2007, 3:46 pm
Press release: "Public.Resource.Org and Fastcase, Inc. announced today that they will release a large and free archive of federal case... [read post]
25 Oct 2017, 5:15 am
C&D Zodiac, Inc, United States Court of Appeals, Federal Circuit, No. 2016-1496, 03 October 2017 appeared first on Kluwer Patent Blog. [read post]
6 Jan 2011, 9:49 am
Uniloc USA, Inc. v. [read post]
10 Oct 2021, 5:18 pm
Pulse Elecs., Inc., 136 S. [read post]
24 Nov 2012, 8:13 am
In Perkinelmer, Inc. v. [read post]
20 Jul 2012, 9:51 am
CytoSport, Inc., Case No. 4:11-cv-03532-CW, 2012 WL 2563857 (N.D. [read post]
2 May 2024, 6:55 am
Inc. v. [read post]
18 Oct 2012, 1:00 am
In Pozen, Inc. v. [read post]
2 May 2013, 1:00 am
Nautilus Inc., the Federal Circuit reversed the district court’s finding that the claims at issue were invalid as indefinite, because the claims were not “insolubly ambiguous. [read post]
17 Apr 2012, 1:00 am
Lansa, Inc. [read post]
24 Oct 2013, 11:00 pm
In Keurig, Inc. v. [read post]
4 Dec 2014, 10:00 pm
Twi Pharmaceuticals, Inc., the Federal Circuit vacated and remanded the district court decision holding the Par claims at issue obvious. [read post]
17 Apr 2012, 1:00 am
Lansa, Inc. [read post]
6 Aug 2012, 1:00 am
Amphastar Pharmaceuticals, Inc., the Federal Circuit held that the safe harbor provisions of 35 USC § 271(e)(1) can shield the defendants from liability for patent infringement arising out of their use of patented methods to... [read post]
